Karen A. Licitra's most recent trade in Angiodynamic Inc was a trade of 17,675 Common Stock done . Disclosure was reported to the exchange on July 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Angiodynamic Inc | Karen A. Licitra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2025 | 17,675 | 90,435 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Karen A. Licitra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 20,541 | 72,760 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Karen A. Licitra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,060 | 35,178 (0%) | 0% | 0 | Common Stock | |
| Angiodynamic Inc | Karen A. Licitra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 5,738 | 28,118 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | Karen A. Licitra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 25 Jun 2021 | 11,111 | 30,205 (0%) | 0% | 4.3 | 48,000 | Common Stock |
| SI-BONE Inc | Karen A. Licitra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 11,111 | 0 | - | - | Stock Option (Right to Buy) | |
| SI-BONE Inc | Karen A. Licitra | Director | Sale of securities on an exchange or to another person at price $ 33.33 per share. | 25 Jun 2021 | 11,111 | 19,094 (0%) | 0% | 33.3 | 370,301 | Common Stock |
| SI-BONE Inc | Karen A. Licitra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 10,297 | 0 | - | - | Stock Option (Right to Buy) | |
| SI-BONE Inc | Karen A. Licitra | Director | Sale of securities on an exchange or to another person at price $ 33.48 per share. | 25 Jun 2021 | 10,297 | 8,797 (0%) | 0% | 33.5 | 344,715 | Common Stock |
| SI-BONE Inc | Karen A. Licitra | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 25 Jun 2021 | 10,297 | 19,094 (0%) | 0% | 4.3 | 44,483 | Common Stock |